Katherine Lietz

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. doi request reprint Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005
    Katherine Lietz
    Cardiovascular and Cardiothoracic Divisions of Columbia University Medical Center, New York, NY, USA
    Circ Heart Fail 2:3-10. 2009
  2. doi request reprint Destination therapy: current results and future promise
    Katherine Lietz
    Center for Advanced Cardiac Care, Columbia Presbyterian Medical Center, New York, New York 10032, USA
    Semin Thorac Cardiovasc Surg 20:225-33. 2008
  3. ncbi request reprint Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005
    Katherine Lietz
    Cardiovascular Division, Georgetown University, Washington Hospital Center, Washington, DC, USA
    J Am Coll Cardiol 50:1282-90. 2007
  4. ncbi request reprint Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection
    Katherine Lietz
    Cardiovascular Division, University of Minnesota, Minneapolis, USA
    Circulation 116:497-505. 2007
  5. doi request reprint The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure
    Katherine Lietz
    Center for Advanced Cardiac Care, Columbia University Medical Center, New York, NY 10032, USA
    J Thorac Cardiovasc Surg 137:1012-9. 2009
  6. doi request reprint Patient selection for left-ventricular assist devices
    Katherine Lietz
    Cardiovascular Divisions, Columbia University Medical Center, New York, New York, USA
    Curr Opin Cardiol 24:246-51. 2009
  7. ncbi request reprint Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease
    Katherine Lietz
    Division of Cardiothoracic Surgery, Columbia Persbyterian Medical Center, New York, NY 10032, USA
    Circulation 112:2468-76. 2005
  8. ncbi request reprint Immunologic sensitization in recipients of left ventricular assist devices
    Ranjit John
    Department of Surgery Cardiology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Thorac Cardiovasc Surg 125:578-91. 2003
  9. ncbi request reprint Immunobiologic consequences of assist devices
    Silviu Itescu
    College of Physicians and Surgeons of Columbia University, 622 West 168th Street, New York, NY 10032, USA
    Cardiol Clin 21:119-33, ix-x. 2003
  10. ncbi request reprint Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria
    Katherine Lietz
    Division of Cardiothoracic Surgery, Columbia Presbyterian Medical Center, Columbia University, New York, New York 10032, USA
    J Am Coll Cardiol 43:1553-61. 2004

Detail Information

Publications20

  1. doi request reprint Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005
    Katherine Lietz
    Cardiovascular and Cardiothoracic Divisions of Columbia University Medical Center, New York, NY, USA
    Circ Heart Fail 2:3-10. 2009
    ..Because most of these patients had surgeries at hospitals that were newly accredited, we sought to examine the impact of LVAD center volume on the outcomes of DT...
  2. doi request reprint Destination therapy: current results and future promise
    Katherine Lietz
    Center for Advanced Cardiac Care, Columbia Presbyterian Medical Center, New York, New York 10032, USA
    Semin Thorac Cardiovasc Surg 20:225-33. 2008
    ..The article summarizes the current state of knowledge and future directions in the field of permanent mechanical circulatory support therapy as an alternative to heart transplantation...
  3. ncbi request reprint Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005
    Katherine Lietz
    Cardiovascular Division, Georgetown University, Washington Hospital Center, Washington, DC, USA
    J Am Coll Cardiol 50:1282-90. 2007
    ..We sought to investigate the actual survival of patients with end-stage heart failure listed for heart transplantation (HT) in the U.S...
  4. ncbi request reprint Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection
    Katherine Lietz
    Cardiovascular Division, University of Minnesota, Minneapolis, USA
    Circulation 116:497-505. 2007
    ..In the present study, we describe outcomes of DT in the post-REMATCH era in the United States...
  5. doi request reprint The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure
    Katherine Lietz
    Center for Advanced Cardiac Care, Columbia University Medical Center, New York, NY 10032, USA
    J Thorac Cardiovasc Surg 137:1012-9. 2009
    ..We sought to determine whether the abrupt restoration of perfusion to the brain after left ventricular assist device (LVAD) implantation produced similar syndromes...
  6. doi request reprint Patient selection for left-ventricular assist devices
    Katherine Lietz
    Cardiovascular Divisions, Columbia University Medical Center, New York, New York, USA
    Curr Opin Cardiol 24:246-51. 2009
    ..The review describes a step-by-step approach to evaluation of patients with end-stage heart failure for LVAD implantation...
  7. ncbi request reprint Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease
    Katherine Lietz
    Division of Cardiothoracic Surgery, Columbia Persbyterian Medical Center, New York, NY 10032, USA
    Circulation 112:2468-76. 2005
    ....
  8. ncbi request reprint Immunologic sensitization in recipients of left ventricular assist devices
    Ranjit John
    Department of Surgery Cardiology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Thorac Cardiovasc Surg 125:578-91. 2003
    ..We investigated the impact of sensitization on posttransplantation outcomes in 105 consecutive left ventricular assist device recipients...
  9. ncbi request reprint Immunobiologic consequences of assist devices
    Silviu Itescu
    College of Physicians and Surgeons of Columbia University, 622 West 168th Street, New York, NY 10032, USA
    Cardiol Clin 21:119-33, ix-x. 2003
    ....
  10. ncbi request reprint Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria
    Katherine Lietz
    Division of Cardiothoracic Surgery, Columbia Presbyterian Medical Center, Columbia University, New York, New York 10032, USA
    J Am Coll Cardiol 43:1553-61. 2004
    ..This study investigates the outcomes of cardiac transplantation using older donors...
  11. ncbi request reprint Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy
    Katherine Lietz
    Transplantation Immunology, Department of Surgery, Columbia Presbyterian Medical Center, New York, NY 10032, USA
    Transplantation 75:781-7. 2003
    ..We investigated whether blockade of the high-affinity interleukin (IL)-2 receptor effectively prevented T-cell alloreactivity in cardiac transplantation...
  12. ncbi request reprint Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure
    Ranjit John
    Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minn, USA
    J Thorac Cardiovasc Surg 134:351-8. 2007
    ..We review our experience with the use of the CentriMag (Levitronix LLC, Waltham, Mass) circulatory support system in such patients whose neurologic status was uncertain...
  13. ncbi request reprint Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients
    Silviu Itescu
    College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Circulation 105:1214-9. 2002
    ..We investigated the effect of cyclophosphamide pulse therapy in sensitized cardiac allograft recipients...
  14. ncbi request reprint Will left-ventricular assist device therapy replace heart transplantation in the foreseeable future?
    Katherine Lietz
    Cardiovascular Division, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Curr Opin Cardiol 20:132-7. 2005
    ....
  15. ncbi request reprint Current understanding and management of allograft vasculopathy
    Katherine Lietz
    Cardiovascular Division, University of Minnesota, Minneapolis, MN 55455, USA
    Semin Thorac Cardiovasc Surg 16:386-94. 2004
    ..In this review, we discuss current understanding of the pathogenesis of CAV, novel diagnostic and therapeutic avenues and explore optimal approaches to risk factors modification...
  16. doi request reprint Heart transplantation in human immunodeficiency virus-positive patients
    Nir Uriel
    Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    J Heart Lung Transplant 28:667-9. 2009
    ..However, with the newer anti-retroviral drugs, the estimated 10-year survival after seroconversion is exceeds 90%. This case series describes the intermediate range outcome of HIV-positive cardiac transplant recipients...
  17. ncbi request reprint Left ventricular assist devices: evolving devices and indications for use in ischemic heart disease
    Katherine Lietz
    Cardiovascular Division, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Curr Opin Cardiol 19:613-8. 2004
    ..Mechanical pumps or devices have been developed called ventricular assist devices and are being used to support an increasing number of patients with refractory heart failure...
  18. ncbi request reprint Perioperative outcomes of cardiac surgery in kidney and kidney-pancreas transplant recipients
    Ranjit John
    Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minn 55455, USA
    J Thorac Cardiovasc Surg 133:1212-9. 2007
    ..We performed a retrospective study of kidney transplant recipients who underwent cardiac surgery over the past 10 years at our institution with an emphasis on evaluating postoperative outcomes...
  19. ncbi request reprint Candidate selection for long-term left ventricular assist device therapy for refractory heart failure
    Leslie W Miller
    Cardiovascular Division, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Heart Lung Transplant 25:756-64. 2006
  20. ncbi request reprint B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression
    Michael Schuster
    College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Hum Immunol 63:211-20. 2002
    ....